Compare PRE & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRE | HRZN |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.7M | 295.1M |
| IPO Year | N/A | N/A |
| Metric | PRE | HRZN |
|---|---|---|
| Price | $20.54 | $4.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $32.00 | $6.80 |
| AVG Volume (30 Days) | 282.8K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 30.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $105.52 | $19.99 |
| Revenue Next Year | $58.16 | $27.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.09 | $4.00 |
| 52 Week High | $22.86 | $9.52 |
| Indicator | PRE | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 18.80 |
| Support Level | $12.35 | N/A |
| Resistance Level | $20.89 | $6.81 |
| Average True Range (ATR) | 1.67 | 0.27 |
| MACD | 0.45 | -0.16 |
| Stochastic Oscillator | 75.65 | 4.37 |
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.